The new device, unveiled at the DNA Vaccines 2010 conference being held in New Orleans, is designed to facilitate mass vaccination.
According to Inovio, existing electroporation systems consist of an electrical pulse generator box the size of a large laptop attached by a cord to a separate needle-electrode applicator. The new CELLECTRA-SP devices combine all components into a self-contained and easy-to-use portable device the size of a cordless hand tool.
The new CELLECTRA(R)-SP products combine the functionality of its current generation of skin and intramuscular electroporation devices in clinical testing with enhanced form, design, and portability. All components from the pulse generator and applicator are integrated into a cordless, rechargeable device. The rechargeable battery can enable vaccination of several hundred subjects, making the device highly amenable to mass vaccination. The devices are designed to accommodate different electrode arrays to meet the requirements of the particular vaccine and tissue for delivery (skin or muscle).
Dr. J. Joseph Kim, president and CEO, stated, “The new CELLECTRA(R)-SP device is a testament to the skills of Inovio’s engineering and research teams. As we look beyond the proof-of-concept stage for our DNA vaccine and delivery programs, our goal is to continue our industry leadership in developing and commercializing new vaccines which could improve the lives of millions of people around the world.”